NovaBay Pharmaceuticals, Inc. 5Y Revenue Growth (CAGR)

5Y Revenue Growth (CAGR) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including 5Y Revenue Growth (CAGR) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 5Y Revenue Growth (CAGR) for 2021 was -6.68% (a -137.55% decrease from previous year)
  • Annual 5Y Revenue Growth (CAGR) for 2020 was 17.79% (a -59.86% decrease from previous year)
  • Annual 5Y Revenue Growth (CAGR) for 2019 was 44.32% (a 51.88% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 5Y Revenue Growth (CAGR) of NovaBay Pharmaceuticals, Inc.

Most recent 5Y Revenue Growth (CAGR)of NBY including historical data for past 10 years.

Interactive Chart of 5Y Revenue Growth (CAGR) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. 5Y Revenue Growth (CAGR) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -6.68%
2020 17.79%
2019 44.32%
2018 29.18%
2017 21.28%
2016 1.55%
2015 -14.79%
2014 -30.71%
2013 -22.59%
2012 -17.55%
2011 -1.52%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology